
Dr Benedikt Westphalen is an oncologist who heads the Centre for Personalised Medicine – Oncology (ZPM-O) at LMU Klinikum in Munich and leads precision oncology at the LMU cancer centre (CCC MünchenLMU). People with cancer see him when extended molecular testing of the tumour may help guide treatment.
What Dr Westphalen treats
Dr Westphalen works in precision oncology, which looks at a tumour’s biological and molecular features as well as the organ where it began and its stage. He is the contact doctor for the LMU precision oncology clinic, which advises whether extended molecular testing makes sense. The centre he heads works like this:
- treating doctors refer the patient, usually on an organ tumour board’s advice;
- tumour tissue is tested at the LMU Institute of Pathology for genetic and other molecular changes;
- a molecular tumour board of oncologists, pathologists, geneticists, organ specialists and bioinformaticians reviews the results;
- its recommendation goes to the treating doctors and is discussed with the patient.
Not every molecular finding opens a new treatment option. See also our page on oncology.
Training and experience
Dr Westphalen holds the title Privatdozent (PD), awarded in Germany after habilitation. He is a clinician scientist at the LMU cancer centre, leads its molecular tumour board and precision oncology programme, and has been an investigator, including principal investigator, on many phase I–III trials in digestive cancers and precision oncology.
He has advised the European Commission’s Cancer Mission Board and the German research ministry on precision oncology, and in January 2024 he became chair of the ESMO Translational Research and Precision Medicine Working Group.
The department and hospital
ZPM-O is part of the LMU cancer centre; its current structure dates from 1 April 2025. Its deputy head is Professor Frederick Klauschen, director of the LMU Institute of Pathology, where molecular pathology testing is done.
The centre also takes part in the genome sequencing model project (Modellvorhaben Genomsequenzierung) and studies everyday precision oncology care in the PEARL study. More on the Comprehensive Cancer Center Munich LMU.
Frequently asked questions
What conditions does Dr Westphalen treat?
Dr Westphalen sees people already diagnosed with cancer when extended molecular testing may point to further options. Precision oncology is not tied to one organ; the LMU oncology department offers it for digestive cancers, rare tumours and cancer of unknown primary (CUP), among others.
How can I see Dr Westphalen from abroad?
Prepare your reports, histology and imaging findings. AlenMed translates them into German and forwards your request; the hospital chooses the route, confirms a date and decides which doctor will see you. Tumour tissue samples may also be requested, because testing is done on tissue.
How much does treatment with Dr Westphalen cost?
The exact amount is set by the hospital in a written estimate (Kostenvoranschlag) prepared before you travel, so you know the costs in advance. It depends on the consultation, molecular testing and treatment needed. Payment goes directly to the hospital.
How to see Dr Westphalen through AlenMed
AlenMed translates your reports into German, agrees a date with the hospital and, if needed, arranges a medical interpreter and personal support. To start, send a request through our form.
This information is for reference only and is not an offer. A doctor decides whether and how to treat after an in-person examination.